BWAY today
$10.25-$0.99 (-8.81%)close Nov 12, 2026Trend
DailyDowntrend (confirmed)
4 hourStrong Bearish
1 hourStrong Bearish
15 minStrong Bearish
5 minStrong Bearish
Daily trend turns up above $14.38
Key levels
Resistance$12.04
Resistance$10.50
Support$9.15
Support$7.99
Latest news & SEC filings
EarningsBrainsWay Posts Q3 2026 Results
EarningsBrainsWay holds Q3 2026 earnings call
GuidanceBrainsWay lifts FY2026 sales guidance to $70.000M from $68.000M-$70.000M
EarningsBrainsWay Posts Quarterly Profit Below Analyst View, Revenue Tops Forecast
All BWAY news →About Brainsway
Brainsway makes medical devices built on its Deep Transcranial Magnetic Stimulation technology, which is used to treat brain conditions including major depression, obsessive-compulsive disorder, and smoking addiction. It sells and leases these systems to psychiatrists, hospitals, and clinics, and also charges per use of installed equipment. The company serves customers in the United States, Israel, and other countries, working with outside partners in some markets.
Based on the company's 20-F filed Apr 20, 2026.
Nasdaq · Healthcare
Brainsway Ltd. (BWAY)
What Is the Price Target for BWAY?
SEPT Low Target
$18.80
SEPT Mid Target
$19.00
SEPT High Target
$20.00
Analyst Consensus
$19.00
Is BWAY a Buy or Sell Right Now?
Thesis
- •Revenue growing 29.0% YoY with ACCELERATING trend — accelerating momentum.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for BWAY.
Start Free Trial →Is BWAY Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
P/E Forward, PEG, Analyst Consensus
Fair Value
$35.15
44
Moat Score
NARROW
5/9
Piotroski Score
N/A
Altman Z-Score
What Is Smart Money Doing with BWAY?
Insider Signal
NEUTRAL
0 buys / 0 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
LOW
Signal: NEUTRAL
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →BWAY Growth Story
Revenue YoY
29.0%
3yr Revenue CAGR
11.4%
EPS Growth YoY
138.46%
FCF Growth YoY
N/A%
Revenue Trend
ACCELERATING
Dark Pool Trades for BWAY
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for BWAY, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 20:57:39 | $10.23 | 1,000 | $$10K | MIDPOINT |
| 20:27:29 | $10.21 | 1,050 | $$11K | SELL |
| 19:57:04 | $10.35 | 1,685 | $$17K | BUY |
| 19:29:03 | $10.30 | 1,000 | $$10K | BUY |
| 18:46:04 | $10.35 | 1,000 | $$10K | SELL |
5 dark pool trades shown · $$59K preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for Brainsway Ltd. (BWAY) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (4 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →BWAY — frequently asked questions
What is BWAY stock price today?
Brainsway Ltd. (BWAY) is at $10.25, down 8.81% (-$0.99) at the Nov 12, 2026 close.
Why is BWAY stock moving today?
Latest BWAY news — Nov 10, 2026: BrainsWay Posts Q3 2026 Results · Nov 10, 2026: BrainsWay holds Q3 2026 earnings call
Why did BWAY stock move on Nov 10, 2026?
BrainsWay reported Q3 2026 results, with earnings per share of $0.05 missing the $0.09 analyst estimate, while revenue of $18.146 million topped the $17.891 million forecast. The company also raised its full-year 2026 sales guidance to $70.000 million from a prior range of $68.000M-$70.000M, above the $69.283 million estimate.
What is the BWAY price target?
The average analyst price target for BWAY is $19.00, ranging from $19 to $20, based on 4 analysts.
What do analysts rate BWAY?
Analyst ratings for BWAY: 1 Buy, 8 Hold, 0 Sell — consensus Hold.
Did BWAY beat earnings?
BWAY last reported on Nov 10, 2026: EPS $0.05 vs $0.09 expected — a miss of 44.4%.
What is BWAY's P/E ratio?
BWAY trades at a P/E of 211.4 vs a Healthcare average of 17.1.
Does BWAY pay a dividend?
BWAY does not currently pay a dividend.
What are BWAY support and resistance levels?
Support: $9.15, $7.99, $7.13. Resistance: $10.50, $12.04, $13.02.
What are insiders doing with BWAY?
Insider activity: NEUTRAL, 0 buys and 0 sells in the last 90 days.
What is the latest news on BWAY?
Nov 10, 2026: BrainsWay Posts Q3 2026 Results · Nov 10, 2026: BrainsWay holds Q3 2026 earnings call · Nov 10, 2026: BrainsWay lifts FY2026 sales guidance to $70.000M from $68.000M-$70.000M